Benazepril Hydrochloride



Benazepril Hydrochloride





(ben a’ za pril)

Lotensin

PREGNANCY CATEGORY D


Drug Classes

ACE inhibitor

Antihypertensive


Therapeutic Actions

Blocks ACE from converting angiotensin I to angiotensin II, a potent vasoconstrictor, leading to decreased BP, decreased aldosterone secretion, a small increase in serum potassium levels, and sodium and fluid loss; increased prostaglandin synthesis also may be involved in the antihypertensive action.


Indications



  • Treatment of hypertension alone or in combination with thiazide diuretics


  • Unlabeled uses: Nondiabetic neuropathy, HF, post MI, diabetes, chronic kidney disease, recurrent stroke prevention



Available Forms

Tablets—5, 10, 20, 40 mg


Dosages

Adults

Initial dose, 10 mg PO daily. Maintenance dose, 20–40 mg/day PO, single or two divided doses. Patients using diuretics should discontinue them 2–3 days prior to benazepril therapy. If BP is not controlled, add diuretic slowly. If diuretic cannot be discontinued, begin benazepril therapy with 5 mg. Maximum dose, 80 mg.

Pediatric patients (6 yr and older)

0.1–0.6 mg/kg/day. Starting dose for monotherapy—0.2 mg/kg/day. Do not exceed 0.6 mg/kg/day (40 mg daily).

Patients with renal impairment

For CrCl less than 30 mL/min (serum creatinine greater than 3 mg/dL), 5 mg PO daily. Dosage may be gradually increased until BP is controlled, up to a maximum of 40 mg/day. Not recommended for children with renal impairment.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Benazepril Hydrochloride

Full access? Get Clinical Tree

Get Clinical Tree app for offline access